Vikash Kansal

7PUBLICATIONS
15CO-AUTHORS
Predictive and prognostic markersLiquid biopsiesMolecular targetsMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 07, 2026
Blueberry Extract Has Anti-Proliferative Activity in Preclinical Models of Head and Neck Cancer.

|Oct 17, 2025
A Practical Method for Detecting Prognostic CD57+ T Cells in Head and Neck Cancer.

Brianna Brammer, Brendan L C Kinney, Vikash Kansal

|Mar 06, 2024
Characterization of the tumor microenvironment in the mouse oral cancer (MOC1) model after orthotopic implantation in the buccal mucosa.

Vikash Kansal, Brendan L C Kinney, Nicole C Schmitt

|May 03, 2023
The expanding role of IAP antagonists for the treatment of head and neck cancer.

Vikash Kansal, Brendan L C Kinney, Srijayaprakash Uppada

|Mar 29, 2023
Epigallocatechin Gallate (EGCG), an Active Phenolic Compound of Green Tea, Inhibits Tumor Growth of Head and Neck Cancer Cells by Targeting DNA Hypermethylation.

Anshu Agarwal, Vikash Kansal, Humaira Farooqi

|Jan 17, 2023
Statin drugs enhance responses to immune checkpoint blockade in head and neck cancer models.

Vikash Kansal, Andre J Burnham, Brendan L C Kinney

Pageof 2

Frequent Collaborators

5 joint publications

Nicole C Schmitt

2 joint publications

Nabil F Saba

2 joint publications

Brendan L C Kinney

2 joint publications

Brianna Brammer